SANIGEN Co., Ltd. Logo

SANIGEN Co., Ltd.

Provides food safety solutions and genetic diagnostics for the entire food industry.

188260 | KO

Overview

Corporate Details

ISIN(s):
KR7188260004
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 흥안대로427번길 16, 411호, 안양시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

SANIGEN Co., Ltd. is a food safety and sanitation company that provides total solutions for the food industry, encompassing manufacturing, distribution, and sales. The company specializes in developing and manufacturing advanced diagnostic products based on microbial genetic analysis technologies, including Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS). Founded in 2005, Sanigen delivers innovative technologies and differentiated services aimed at establishing hygienic manufacturing environments and ensuring food safety, with a mission to protect human health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-08 00:00
Regulatory News Service
거래처와의거래중단
Korean 7.2 KB
2025-09-01 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 128.7 KB
2025-08-21 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.9 KB
2025-08-21 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 131.3 KB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 17.5 KB
2025-03-18 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.6 MB
2025-03-13 00:00
Audit Report / Information
감사보고서제출
Korean 18.5 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 6.4 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 5.0 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 170.2 KB
2025-03-06 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 100.2 KB
2025-02-13 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.1 KB
2025-02-13 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB

Automate Your Workflow. Get a real-time feed of all SANIGEN Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SANIGEN Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SANIGEN Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America
ABEO
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom
ABDX

Talk to a Data Expert

Have a question? We'll get back to you promptly.